SCHEMBL9998185

SCHEMBL9998185

CC(=O)OCC=Cc1ccccc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 4/20 0.41
TSHR P16473 2/20 0.41
RAB9A P51151 3/20 0.39
PTGER1 P34995 2/20 0.39
PTGER4 P35408 2/20 0.39
PTGER3 P43115 2/20 0.39
PTGER2 P43116 2/20 0.39
KDM4E B2RXH2 3/20 0.38
LMNA P02545 2/20 0.38
GMNN O75496 1/20 0.38
PMP22 Q01453 1/20 0.38
NPC1 O15118 2/20 0.36
CACNA1B Q00975 1/20 0.36
POLB P06746 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
THPO P40225 1/20 0.36
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998182 1.00 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1TSHRRAB9APTGER1
SCHEMBL27961278 0.87 PTGER1 (0.42) SMN1; SMN2ALDH1A1TSHRRAB9APTGER1
SCHEMBL28453539 0.84 NFE2L2 (0.40) SMN1; SMN2ALDH1A1TSHRPTGER1PTGER4
SCHEMBL1039973 0.83 MAPT (0.54) ALDH1A1RAB9AKDM4ELMNANPC1
SCHEMBL9997452 0.82 MEN1 (0.46) SMN1; SMN2RAB9ALMNANPC1MAPT
SCHEMBL9998651 0.82 NFE2L2 (0.47) SMN1; SMN2ALDH1A1RAB9ANPC1CYP1A2
SCHEMBL9998642 0.82 ALDH1A1 (0.40) ALDH1A1PTGER1PTGER4PTGER3PTGER2
SCHEMBL9997271 0.82 HSD11B1 (0.50) ALDH1A1KDM4ELMNANPC1POLB
SCHEMBL9997449 0.82 MEN1 (0.46) SMN1; SMN2RAB9ALMNANPC1MAPT
SCHEMBL9998652 0.82 NFE2L2 (0.47) SMN1; SMN2ALDH1A1RAB9ANPC1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 SMN1; SMN2 3151/4885ALDH1A1 160/4885TSHR 621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.